Global Pigmentation Disorder Therapeutic Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05245169

Publication Date:

May 24, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color.
The global Pigmentation Disorder Therapeutic market size is projected to grow from US$ 5930.1 million in 2023 to US$ 8442.9 million in 2030; it is expected to grow at a CAGR of 5.2% from 2024 to 2030.
The 鈥淧igmentation Disorder Therapeutic Industry Forecast鈥� looks at past sales and reviews total world Pigmentation Disorder Therapeutic sales in 2023, providing a comprehensive analysis by region and market sector of projected Pigmentation Disorder Therapeutic sales for 2024 through 2030. With Pigmentation Disorder Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pigmentation Disorder Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Pigmentation Disorder Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pigmentation Disorder Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pigmentation Disorder Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pigmentation Disorder Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pigmentation Disorder Therapeutic.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Pigmentation Disorder Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by type
Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
Segmentation by application
Dermatology Clinics
Drugstores and Cosmetic Stores
Aesthetic Clinics
E-commerce
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
Allergan
Episciences
La Roche-Posay
SkinCeuticals
Pierre Fabre
Alvogen
Obagi

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pigmentation Disorder Therapeutic Market Size 2019-2030
2.1.2 Pigmentation Disorder Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pigmentation Disorder Therapeutic Segment by Type
2.2.1 Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
2.2.2 Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
2.3 Pigmentation Disorder Therapeutic Market Size by Type
2.3.1 Pigmentation Disorder Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pigmentation Disorder Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Pigmentation Disorder Therapeutic Segment by Application
2.4.1 Dermatology Clinics
2.4.2 Drugstores and Cosmetic Stores
2.4.3 Aesthetic Clinics
2.4.4 E-commerce
2.4.5 Others
2.5 Pigmentation Disorder Therapeutic Market Size by Application
2.5.1 Pigmentation Disorder Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pigmentation Disorder Therapeutic Market Size Market Share by Application (2019-2024)
3 Pigmentation Disorder Therapeutic Market Size by Player
3.1 Pigmentation Disorder Therapeutic Market Size Market Share by Players
3.1.1 Global Pigmentation Disorder Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Pigmentation Disorder Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Pigmentation Disorder Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pigmentation Disorder Therapeutic by Regions
4.1 Pigmentation Disorder Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Pigmentation Disorder Therapeutic Market Size Growth (2019-2024)
4.3 APAC Pigmentation Disorder Therapeutic Market Size Growth (2019-2024)
4.4 Europe Pigmentation Disorder Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Pigmentation Disorder Therapeutic Market Size Growth (2019-2024)
5 Americas
5.1 Americas Pigmentation Disorder Therapeutic Market Size by Country (2019-2024)
5.2 Americas Pigmentation Disorder Therapeutic Market Size by Type (2019-2024)
5.3 Americas Pigmentation Disorder Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pigmentation Disorder Therapeutic Market Size by Region (2019-2024)
6.2 APAC Pigmentation Disorder Therapeutic Market Size by Type (2019-2024)
6.3 APAC Pigmentation Disorder Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pigmentation Disorder Therapeutic by Country (2019-2024)
7.2 Europe Pigmentation Disorder Therapeutic Market Size by Type (2019-2024)
7.3 Europe Pigmentation Disorder Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pigmentation Disorder Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pigmentation Disorder Therapeutic Market Forecast
10.1 Global Pigmentation Disorder Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Pigmentation Disorder Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Pigmentation Disorder Therapeutic Forecast
10.1.3 APAC Pigmentation Disorder Therapeutic Forecast
10.1.4 Europe Pigmentation Disorder Therapeutic Forecast
10.1.5 Middle East & Africa Pigmentation Disorder Therapeutic Forecast
10.2 Americas Pigmentation Disorder Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Pigmentation Disorder Therapeutic Market Forecast
10.2.2 Canada Pigmentation Disorder Therapeutic Market Forecast
10.2.3 Mexico Pigmentation Disorder Therapeutic Market Forecast
10.2.4 Brazil Pigmentation Disorder Therapeutic Market Forecast
10.3 APAC Pigmentation Disorder Therapeutic Forecast by Region (2025-2030)
10.3.1 China Pigmentation Disorder Therapeutic Market Forecast
10.3.2 Japan Pigmentation Disorder Therapeutic Market Forecast
10.3.3 Korea Pigmentation Disorder Therapeutic Market Forecast
10.3.4 Southeast Asia Pigmentation Disorder Therapeutic Market Forecast
10.3.5 India Pigmentation Disorder Therapeutic Market Forecast
10.3.6 Australia Pigmentation Disorder Therapeutic Market Forecast
10.4 Europe Pigmentation Disorder Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Pigmentation Disorder Therapeutic Market Forecast
10.4.2 France Pigmentation Disorder Therapeutic Market Forecast
10.4.3 UK Pigmentation Disorder Therapeutic Market Forecast
10.4.4 Italy Pigmentation Disorder Therapeutic Market Forecast
10.4.5 Russia Pigmentation Disorder Therapeutic Market Forecast
10.5 Middle East & Africa Pigmentation Disorder Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Pigmentation Disorder Therapeutic Market Forecast
10.5.2 South Africa Pigmentation Disorder Therapeutic Market Forecast
10.5.3 Israel Pigmentation Disorder Therapeutic Market Forecast
10.5.4 Turkey Pigmentation Disorder Therapeutic Market Forecast
10.5.5 GCC Countries Pigmentation Disorder Therapeutic Market Forecast
10.6 Global Pigmentation Disorder Therapeutic Forecast by Type (2025-2030)
10.7 Global Pigmentation Disorder Therapeutic Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Pigmentation Disorder Therapeutic Product Offered
11.1.3 Bayer Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Pigmentation Disorder Therapeutic Product Offered
11.2.3 Allergan Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Episciences
11.3.1 Episciences Company Information
11.3.2 Episciences Pigmentation Disorder Therapeutic Product Offered
11.3.3 Episciences Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Episciences Main Business Overview
11.3.5 Episciences Latest Developments
11.4 La Roche-Posay
11.4.1 La Roche-Posay Company Information
11.4.2 La Roche-Posay Pigmentation Disorder Therapeutic Product Offered
11.4.3 La Roche-Posay Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 La Roche-Posay Main Business Overview
11.4.5 La Roche-Posay Latest Developments
11.5 SkinCeuticals
11.5.1 SkinCeuticals Company Information
11.5.2 SkinCeuticals Pigmentation Disorder Therapeutic Product Offered
11.5.3 SkinCeuticals Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 SkinCeuticals Main Business Overview
11.5.5 SkinCeuticals Latest Developments
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Information
11.6.2 Pierre Fabre Pigmentation Disorder Therapeutic Product Offered
11.6.3 Pierre Fabre Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pierre Fabre Main Business Overview
11.6.5 Pierre Fabre Latest Developments
11.7 Alvogen
11.7.1 Alvogen Company Information
11.7.2 Alvogen Pigmentation Disorder Therapeutic Product Offered
11.7.3 Alvogen Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Alvogen Main Business Overview
11.7.5 Alvogen Latest Developments
11.8 Obagi
11.8.1 Obagi Company Information
11.8.2 Obagi Pigmentation Disorder Therapeutic Product Offered
11.8.3 Obagi Pigmentation Disorder Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Obagi Main Business Overview
11.8.5 Obagi Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂